Identification of Selective Imidazopyridine CSF1R Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of Selective Imidazopyridine CSF1R Inhibitors

Published:2024-04-30 Issue:5 Volume:15 Page:722-730
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Kane John L.¹^ORCID,Asmussen Gary¹,Batchelor Joseph¹,Cromwell Mandy²,Fezoui Malika²,Fitzgerald Maria³^ORCID,Giese Barret¹,Gladysheva Tatiana¹,Holley Stephanie¹,Keefe Kelly²,Kothe Michael¹,Lam Becky¹,Lim Sungtaek¹,Liu Jinyu¹,Ma Liang¹,Metz Markus¹,Scholte Andrew A.¹,Shum Patrick¹,Wei LinLi¹,Woodworth Lisa²,Edling Andrea²

Affiliation:

1. Integrated Drug Discovery, Sanofi R&D, 350 Water Street, Cambridge, Massachusetts 02141, United States

2. Rare and Neurologic Disease Research, Sanofi R&D, 350 Water Street, Cambridge, Massachusetts 02141, United States

3. Drug Metabolism and Pharmacokinetics, Sanofi R&D, 350 Water Street, Cambridge, Massachusetts 02141, United States

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.4c00110

Reference23 articles.

1. Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases

2. Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer

3. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

4. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP